tbuckley/cabot-search huggingface dataset:
DEATH OF DR. W. E. B. DAVIS.
Journal: JAMA (1903)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Introduction
Authors: J. Eyer, S.V. Kasl, S. Cobb, F. Kittel, M. Kornitzer, M. Dramaix, N. van Dijkhuizen, H. Reiche, T. Theorell, L.J.P van Doornen, David Jenkins, Stephen J. Zyzanski, F. Verhagen, C. Nass, A. Appels, A. van Bastelaer, J. Winnubst, A. Appels, H. van Dijl, N. Nagelkerke
Journal: Psychotherapy and Psychosomatics (1980)
Psychopharmacology
Authors: Domenic A. Ciraulo
Journal: JAMA (2004)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cardiac rate and rhythm in mice affected by haloalkane propellants
Authors: J. L. Egle
Journal: JAMA (1972)

Haloalkane gases, used as aerosol propellants, have been reported to cause death presumably by means of cardiotoxic reaction. The influence of these agents on cardiac activity and cardiac responses to asphyxia were studied in anesthetized mice. The animals were exposed to either nitrogen, propellant, propellant plus isoproterenol, or propellant plus albuterol, and then asphyxiated for two minutes. Exposure to propellant propellant plus isoproterenol, or propellant plus albuterol did not shorten the onset time nor increase the severity of the asphyxia-induced bradycardia. The frequency of 2:1 atrioventricular (AV) block was not significantly altered by exposure to the propellant or propellant mixtures. Exposure to nitrogen hastened the development of bradycardia and increased the number of 2:1 AV events during asphyxia. These results suggest that inhalation of haloalkane propellants does not sensitize the myocardium to arrhythmias induced by asphyxia.
CHEMOTHERAPEUTIC CONSIDERATIONS OF PENTAVALENT AND TRIVALENT ARSENIC
Journal: JAMA (1922)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Cambridge Diet
Authors: Alan N. Howard
Journal: JAMA (1984)

<h3>To the Editor.—</h3> The unreasonable attack on the Cambridge Diet<sup>1</sup>illustrates the hysteria that can unfortunately infect even members of the medical community. It is claimed that the Cambridge Diet is fundamentally unsafe and can cause death. There is absolutely no evidence for this point of view. Dr James Carman of Berkeley showed that 5 million persons had used the Cambridge Diet in 2 1/2 years up to November 1982 and that it was the only source of food for four weeks or more for about 850,000 (17%) persons (personal communication). This is nearly nine times the similar use of the liquid protein diets. On the basis of statistical probability alone, approximately two deaths per 100,000 persons per year would be expected to occur in a comparable nondieting group of persons. The Food and Drug Administration received only six reports of deaths of persons who, coincidentally, were using the
THE CRITERIA OF SENILITY.
Journal: JAMA (1997)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Clinical Gastroenterology.
Authors: Ivan J. Kahn
Journal: JAMA (1963)

As indicated in the preface to the first edition, this volume discusses gastroenterology as a clinical subject for those interested in "bedside medicine." Experimental gastroenterology is specifically excluded. This is at once the source of the book's greatest strength and greatest weakness. A book is welcome when a capable, observant individual with vast clinical experience can present his data in an unusual and refreshing way. Particularly good are those chapters which deal with subjects in which the author has a special interest, such as the esophagus and portal hypertension. In addition, several chapters, such as those on the tongue and pharynx, the abdomen in general, the colon, and the anorectal area, present clinical information with especial completeness and clarity. The book's biggest drawback, its persistent failure to draw on the enormous body of experimental evidence now available, tends to make the discussion of many subjects rather superficial. Consequently, those not
NEURAL DYNAMICS.
Authors: W. J. HERDMAN
Journal: JAMA (1898)

The learned author of our most recent work on the nervous system and its diseases has said: "Some knowledge of the dynamics of the nervous tissues is of fundamental importance to the student of nervous phenomena and nervous disease, who should know something of the stimuli to which nerve-cells and nerve fibers react; of the manner and degree of this reaction; of the phenomena by which it is attended and of the nature of molecular transmission." (Chas. K. Mills.) Progress in clearing up the mysteries which attend especially the origin of functional disorders of the nervous system requires more complete and exact knowledge of neural dynamics. And as the organic changes are but the secondary stages of disorders which were necessarily functional in the beginning of the derangement, faulty dynamics must account for these also. In the nervous system, exhibiting vital phenomena either of normal or abnormal nature, we have
Smoking and Perinatal Mortality: 'No Significant Relationship'
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Allergic Shiners
Authors: Robert E. Carlson
Journal: JAMA (1981)

<h3>To the Editor.—</h3> The response by Gerald A. Gellin, MD (1981;245:1165), to the question "Dark Circles Around the Eyes," failed to mention the phenomenon of "allergic shiners." This stigmata of allergic rhinitis—dark, often swollen circles below the eyes— is thought to be caused by stasis of blood secondary to pressure on the veins from edema of the mucous membranes of the nasal and paranasal cavities.<sup>1-3</sup>Thus, the presence of dark circles around and especially under the eyes should prompt the physician to search carefully for signs and symptoms of allergic disease.
Bicyclol mitigates acute liver injury via inhibition of ferroptosis by modulating GPx4/Xc-system activity
Authors: Tianming Zhao, Xiaofei Fan, You Deng, Lijun Hou, Lihong Mao, Junjie Hou, Bangmao Wang, Xiaocang Cao, Chao Sun
Journal: Journal of Hepatology (2020)
Dermatologists, university join in skin cancer study
Journal: JAMA (1984)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The role of fibroblast growth factor-2 in the vascular effects of interleukin-1 in porcine coronary arteries in vivo
Authors: A. Ito, H. Shimokawa, Y. Fukumoto, T. Kadokami, R. Nakaike, T. Takayanagi, K. Egashira, K. Sueishi, A. Takeshita
Journal: Cardiovascular Research (1996)

We recently demonstrated that chronic treatment with interleukin-1β (IL-1β), a major inflammatory cytokine found in atherosclerotic lesions, induces coronary arteriosclerotic changes and vasospastic responses to serotonin and histamine in pigs in vivo and that those responses are partially mediated by platelet-derived growth factor (PDGF). This study was designed to examine, first, whether the effects of IL-1β are also partially mediated by fibroblast growth factor-2 (FGF-2), which is another important growth factor in atherosclerotic lesions, and, secondly, whether chronic treatment with FGF-2per se also induces histological and functional changes in porcine coronary arteries in vivo.Methods: Porcine coronary arteries were aseptically wrapped with cotton mesh absorbing IL-1β with or without neutralizing antibody to FGF-2. In a separate series of experiments porcine coronary arteries were chronically treated with FGF-2 itself in the same manner. Coronary vascular responses in vivo and histological changes were examined 2 weeks after the operation.Results: Coronary vasospastic responses to serotonin and histamine and neointimal formation were induced at the site of the coronary artery where IL-1β was chronically and locally applied. These responses were significantly suppressed by co-treatment with a neutralizing antibody to FGF-2 but not by that with non-immune IgG. Immunostaining revealed the presence of FGF-2 in the endothelial cells, the thickened intima and the media at the IL-1β-treated site. Furthermore, chronic treatment with FGF-2 also induced coronary vasospastic responses to serotonin and histamine and neointimal formation.Conclusions: These results suggest that the vascular effects of IL-1β may also be mediated by FGF-2 in our swine model and that chronic treatment with FGF-2 also causes coronary arteriosclerotic changes and vasospastic responses in vivo.
PRACTICAL NOTES.
Journal: JAMA (1890)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Books Received.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Cover
Authors: M. Therese Southgate
Journal: JAMA (1997)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Inflammatory Bowel Disease
Authors: Howard Spiro
Journal: JAMA (1996)

This fourth edition of a book devoted to inflammatory bowel disease (IBD) provides, as the editors promise, "an up-to-date and comprehensive resource." As a dissenter and a "grouper," I was pleased, given the current belief that there are inflammatory bowel diseases, to have the editors retain the singular form in the title. Drs Kirsner and Shorter continue to provide the best compendium on IBD, lovingly bound if somewhat stinting in its margins. I always look over a book's references first to see how up-to-date they are, even though I recognize that books take a long time to appear, on average a year after the manuscript is completed. In this book, 1993 marked the outer boundary, which is about what one would expect; a few chapters had references even from 1994. There's certainly far more than anyone will want to sit down and read straight through, but if you wish to
A Nurse's Guide for the Operating Room. Second Edition. Enlarged and Revised.
Journal: JAMA (1905)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
In Reply
Authors: Stefanos Bonovas, Kalitsa Filioussi, Nikolaos Tsavaris, Nikolaos M. Sitaras
Journal: Journal of Clinical Oncology (2006)

Trock in regard to our article 1 published in the Journal of Clinical Oncology.They make some points with which we certainly agree and others we would like to discuss.Our meta-analysis provides evidence that statin use is not associated with a substantially decreased or increased risk of breast cancer.However, Prowell et al suggest that lipophilic statins may have a different chemopreventive potential than lipophobic (pravastatin).To investigate this hypothesis, we performed additional subgroup analyses.3][4] Approximately 7,000 women were randomly assigned in these trials, with an average follow-up of approximately 5.5 years.The overall incidence of breast cancer was 1.78% (123 incident cases).The association of statin use with breast cancer was once again not statistically significant (random effects model: relative risk [RR], 0.97; 95% CI, 0.60 to 1.55; fixed effects model: RR, 0.89; 95% CI, 0.63 to 1.27; I 2 ϭ 25%).However, the small number of cases limited the statistical power and resulted in wide confidence intervals.Prowell et al correctly mention that the observational studies included in our meta-analysis are limited by the use of multiple statins, doses, and treatment durations.They state that this can create a misclassification bias that tends to drive the observed RRs toward 1.0; masking a potential protective effect of statins.However, this applies only in the case of nondifferential exposure misclassification.Even slight deviations from completely nondifferential misclassification can lead to large biases away from the null. 5egarding the retrospective case-control study of Kochhar et al 6 presented at the 41st Annual Meeting of the American Society of Clinical Oncology in 2005, we have to mention that our study was completed in April 2005, in accordance with the study protocol.Thus, it was impossible to have included this abstract in our meta-analysis.For the same reason, a very large study of 75,828 women, 7 with 6 to 12 years of follow-up and 3,177 incident breast cancer cases, was also not included in our meta-analysis.This prospective study suggested that statin use is not significantly associated with breast cancer risk (RR, 0.91; 95% CI, 0.76 to 1.08).Clearly, laboratory investigation should be conducted to further define the biologic mechanisms by which statins induce apoptosis and reduce cell invasiveness in various cell lines, including breast carcinoma cells.However, the question of whether the current epidemiologic data provide a basis for randomized clinical trials needs to be examined carefully.